Cleargreens Pharmaceuticals

India
Develops and markets pharmaceutical APIs, offers regulatory support, and facilitates trading services.

About Cleargreens Pharmaceuticals

Cleargreens Pharmaceuticals is a Healthcare company based in India by Pravin Navle, Chetan Majmudar, and Ramesh Kalavadia. It develops and markets pharmaceutical APIs, offers regulatory support, and facilitates trading services. It operates on a B2B model. Its Indian entity Cleargreens Pharmaceuticals Private Limited reported revenue of β‚Ή44.00 Cr. Cleargreens Pharmaceuticals offers products and services including API Products, Regulatory Support, and Trading Services. Its focus areas include Supply Chain, Trading, Pharmaceutical Materials and Pharmaceuticals. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.

Company details

Cleargreens Pharmaceuticals Pvt. Ltd. focuses on developing and marketing niche Active Pharmaceutical Ingredients (APIs) with non-infringing routes. They provide comprehensive regulatory support through Drug Master Files (DMF) and assist with import substitutions. Based in Ahmedabad, India, they work closely with clients seeking cost-effective sourcing and compliance. Their trading services connect suppliers and customers for primary packaging materials and APIs.

Key Metrics
  • Annual Revenue
    ₹44.00 Cr

    FY 2025 · +21% YoY

  • Net Profit
    ₹5.37 Cr

    FY 2025 · 12% margin

  • EBITDA
    ₹7.50 Cr

    FY 2025 · 17% margin

Products & Services of Cleargreens Pharmaceuticals

Cleargreens Pharmaceuticals offers a comprehensive portfolio of products and services, including API Products, Regulatory Support, and Trading Services.

API Products
Pharmaceutical Ingredients

Develops and markets niche APIs for generic and import substitution needs.

Regulatory Support
Compliance Services

Offers DMF support for API compliance and regulatory requirements.

Trading Services
Supply Chain Solutions

Facilitates sourcing of packaging materials and APIs at lower costs.

Board of directors of Cleargreens Pharmaceuticals Private Limited (Cleargreens Pharmaceuticals)

Cleargreens Pharmaceuticals Private Limited is the primary company behind Cleargreens Pharmaceuticals. The board of Cleargreens Pharmaceuticals Private Limited currently have 3 directors; the longest-serving is Nisha Pravin Navle, appointed in 2017. 2 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Nisha Pravin Navle
DIN 07713948
Director05 Apr 20179 yrs 6 moCleargreens Pharmaceuticals Private Limited
Ramesh Kalawadia Makanbhai
DIN 07713939
Director05 Apr 20179 yrs 6 moCleargreens Pharmaceuticals Private Limited
Chetan Satyendra Majmudar
DIN 10051967
Director01 Apr 20233 yrs 7 moCleargreens Pharmaceuticals Private Limited

People of Cleargreens Pharmaceuticals

3 people are tracked at Cleargreens Pharmaceuticals (3 in leadership).

NameRoleGroup
Co-FounderLeadership
Co-FounderLeadership
Ramesh Kalavadia
Co-FounderLeadership
Premium access

Complete people profiles for Cleargreens Pharmaceuticals

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Cleargreens Pharmaceuticals

Figures of Cleargreens Pharmaceuticals Private Limited, the primary company behind Cleargreens Pharmaceuticals, for FY 2025. Revenue was ₹44.00 Cr (+21% year on year). Net profit was ₹5.37 Cr (12% margin). EBITDA was ₹7.50 Cr (17% margin). Revenue has grown at a compounded annual rate of +1% over three years and -1% over five years.

  • ₹44.00 CrRevenue · FY 2025 · +21% YoY
  • ₹5.37 CrNet profit · 12% margin
  • ₹7.50 CrEBITDA · 17% margin
  • ₹10 LakhPaid-up capital
  • +1%Revenue CAGR, 3 years
  • -1%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Cleargreens Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Cleargreens Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Cleargreens Pharmaceuticals

Cleargreens Pharmaceuticals has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
lauruslabs.com2005Hyderabad, India$229.73M6,035
Pharmaceutical and biotechnology company
symbiotec.in2002Indore, India$61.01M1,822
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
sequent.in2002Bengaluru, India
APIs are developed and manufactured for therapeutic areas.
Premium access

Detailed similar companies of Cleargreens Pharmaceuticals

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Cleargreens Pharmaceuticals

Cleargreens Pharmaceuticals is headquartered in India.

The primary company behind Cleargreens Pharmaceuticals, Cleargreens Pharmaceuticals Private Limited, reported revenue of β‚Ή44.00 Cr for FY 2025, up 21% year on year.

Cleargreens Pharmaceuticals Pvt. Ltd. focuses on developing and marketing niche Active Pharmaceutical Ingredients (APIs) with non-infringing routes. They provide comprehensive regulatory support through Drug Master Files (DMF) and assist with import substitutions. Based in Ahmedabad, India, they work closely with clients seeking cost-effective sourcing and compliance. Their trading services connect suppliers and customers for primary packaging materials and APIs.

Cleargreens Pharmaceuticals's top competitors include Laurus Labs, Symbiotec and SeQuent.

Cleargreens Pharmaceuticals offers API Products, Regulatory Support, and Trading Services.

Cleargreens Pharmaceuticals operates through Cleargreens Pharmaceuticals Private Limited.

The legal entities of Cleargreens Pharmaceuticals currently have 3 directors, including Nisha Pravin Navle, Ramesh Kalawadia Makanbhai, Chetan Satyendra Majmudar.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available